Innovation in Neonatal Neurotechnology

The CergenX Wave is a medical device that leverages AI to identify newborn infants who are most at risk of brain injury.

Innovation in Neonatal Neurotechnology

The CergenX Wave is a medical device that leverages AI to identify newborn infants who are most at risk of brain injury.

Innovation in Neonatal Neurotechnology

The CergenX Wave is a medical device that leverages AI to identify newborn infants who are most at risk of brain injury.

Innovation in Neonatal Neurotechnology

The CergenX Wave is a medical device that leverages AI to identify newborn infants who are most at risk of brain injury.

The Clinical Problem

Is This Newborn's Brain Health At Risk?

Is This Newborn's Brain Health At Risk?

Is This Newborn's Brain Health At Risk?

In the immediate postnatal period, healthcare professionals often face a daunting challenge: determining the neurological well-being of a newborn. Current tools and methods for assessing brain health have limitations and are often subjective. Newborn brain injury needs to be identified as soon as possible so that appropriate treatments and interventions are initiated. Time is precious, expertise is scarce, and ensuring the best care is our top priority.

In the immediate postnatal period, healthcare professionals often face a daunting challenge: determining the neurological well-being of a newborn. Current tools and methods for assessing brain health have limitations and are often subjective. Newborn brain injury needs to be identified as soon as possible so that appropriate treatments and interventions are initiated. Time is precious, expertise is scarce, and ensuring the best care is our top priority.

140m

140m

140m

140m

babies are born worldwide

per year

babies are born worldwide per year

babies are born worldwide per year

babies are born worldwide per year

5 in 1000

babies are known to be born with a brain injury

50%

of Cerebral Palsy cases are undetected at birth

Electroencephalography (EEG) is a direct measure of the electrical activity of the brain (brain waves).

Patterns in the EEG provide real-time information about brain function and identify babies at risk of brain injury quickly. However, recording a clinical EEG is expensive, time consuming, and requires expert interpretation. It is generally only available in specialist centres. As a result, many babies are not assessed at birth and may not benefit from early intervention and treatment.

Missed diagnoses can lead to a range of challenges.

These include learning difficulties, physical disabilities, and emotional and behavioural problems. They can persist throughout an individual’s life. The impact extends beyond the individual, as families may face emotional stress and financial hardship due to long-term care needs, and healthcare systems bear the weight of increased demand for specialised services and support.

Introducing CergenX Wave

Pioneering Neonatal Neurological Care

Pioneering Neonatal Neurological Care.

Pioneering Neonatal Neurological Care

CergenX Wave is our AI-powered innovation in neonatal neuroprotective care. Wave revolutionises the assessment of newborn brain function offering fast insights informed by expertise, right at the point of care, in just 15 minutes. Our device bridges the gap in evaluating newborn brain health, providing a reliable, accessible, data-driven solution for critical decisions in time-sensitive care situations. 

CergenX Wave is our AI-powered innovation in neonatal neuroprotective care. Wave revolutionises the assessment of newborn brain function offering fast insights informed by expertise, right at the point of care, in just 15 minutes. Our device bridges the gap in evaluating newborn brain health, providing a reliable, accessible, data-driven solution for critical decisions in time-sensitive care situations. 

CergenX Wave is our AI-powered innovation in neonatal neuroprotective care. Wave revolutionises the assessment of newborn brain function offering fast insights informed by expertise, right at the point of care, in just 15 minutes. Our device bridges the gap in evaluating newborn brain health, providing a reliable, accessible, data-driven solution for critical decisions in time-sensitive care situations. 

Targeting the right patient, in the right place, at the right time.

15 Minute

Test

Simple &

Easy to Use

For Use by
All Clinicians

Objective
Decision Support

Automated AI

EEG Assessment

Our Network